Navigation Links
Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash
Date:5/20/2013

epend upon future circumstances that may or may not occur.

Examples of such forward looking statements include (but are not limited to) statements about expected benefits and risks associated with the Increased Offer; projections or expectations of profit attributable to shareholders; anticipated provisions or write-downs, economic profit, dividends, capital structure or any other financial items or ratios; statements of plans, objectives or goals of Elan, the Elan Group, RP Management or Royalty Pharma following the Increased Offer; statements about the future trends in interest rates, liquidity, foreign exchange rates, stock market levels and demographic trends and any impact that those matters may have on Elan, the Elan Group, RP Management or Royalty Pharma following the Increased Offer; statements concerning any future Irish, US or other economic environment or performance; statements about strategic goals, competition, regulation, regulatory approvals, dispositions and consolidation or technological or regulatory developments; and statements of assumptions underlying such statements.

Forward looking statements only speak as of the date on which they are made, and the events discussed in this announcement may not occur. Subject to compliance with applicable law and regulation, Royalty Pharma is not under any obligation to update publicly or revise forward looking statements, whether as a result of new information, future events or otherwise.

Rule 8 - Dealing Disclosure Requirements

Under the provisions of Rule 8.3 of the Irish Takeover Rules, if any person is, or becomes, "interested" (directly or indirectly) in 1% or more of any class of "relevant securities" of Elan, all "dealings" in any "relevant securities" of Elan (including by means of an option in respect of, or a derivative referenced to, any such "relevant securities") must be publicly disclosed by not later than 3.30 pm (Irish time) on the "business day" following the date
'/>"/>

SOURCE Royalty Pharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Royalty Rates Take Center Stage in Biopharma Dealmaking
2. Royalty Pharma Announces Proposal To Acquire Elan
3. PDL BioPharma Provides First Quarter 2013 Royalty Revenue Guidance of $92 Million
4. Royalty Rates for Pharmaceuticals & Biotechnology: Real-Deal Information for Hundreds of Transactions
5. PDL BioPharma Completes Structured Financing and Royalty Transaction with Avinger
6. Selexis SA Sells Rights to Royalty Payments for More Than 15 Biologic Development Programs to Ligand Pharmaceuticals
7. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
8. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
9. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
10. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
11. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)...  Corporate libraries are constantly being faced with a ... and how to cope with flat or shrinking budgets. ... medical device industries are increasingly finding it challenging to ... provide. According to recent research by ... of change that leading corporate libraries are being faced ...
(Date:7/25/2014)... Calif. , July 25, 2014  Depomed, Inc. ... will release second quarter fiscal year 2014 financial results ... Company will host a conference call beginning at 4:30 ... Participants can access the call by dialing 877-317-6789 ( ... conference call will also be available via a live ...
(Date:7/25/2014)... Calif. , July 25, 2014 /PRNewswire-iReach/ -- ... Nieto as the new Vice President of Business ... over 30 years in a number of different business ... the industry. These positions were primarily related to business ... over the past 30 years makes him a key ...
Breaking Medicine Technology:Forces of Change Reshaping Corporate Libraries & Information Services 2Depomed To Report Second Quarter Fiscal Year 2014 Financial Results On Wednesday, August 6, 2014 2Contract Research Organization WCCT Global Welcomes Peter Nieto as Vice President of Business Development 2
... Misonix, Inc. (NASDAQ: MSON ), ... markets innovative therapeutic ultrasonic products worldwide for wound ... and other surgical and medical applications, has entered ... Osteotrauma Ltda., based in Concepcion, Chile. Osteotrauma will ...
... 1, 2011 /PRNewswire-USNewswire/ – CoMeD – On ... Programme (UNEP) distributed a revised text for ... mercury-free drugs were gratified to see pharmaceuticals listed in ... treaty. The Coalition for Mercury-free Drugs ...
Cached Medicine Technology:Misonix Announces New Distribution Agreement for Chile 2Misonix Announces New Distribution Agreement for Chile 3Global Mercury Treaty May Include Ban on Mercury in Medicine 2Global Mercury Treaty May Include Ban on Mercury in Medicine 3
(Date:7/28/2014)... "We experienced difficulty filling our pill boxes ... inventors from Jamestown, Calif. "We came up with this ... could pour medications in more easily." , They created ... the lids open as the pill box is filled. ... have been filled. This eliminates hassles and frustrations, and ...
(Date:7/28/2014)... 2014 Scientists in Japan have completed ... blood test for the asbestos cancer mesothelioma. Surviving Mesothelioma ... Click here to read it now. , ... Juntendo University Graduate School of Medicine say a new ... step above the old test. , “Particularly for ...
(Date:7/28/2014)... 2014 The research found that most ... food best, with each subsequent bite being less satisfying ... actually serve to sabotage the meal. , "People ... not realizing the effect," Baba Shiv, the study's author, ... moderation, if we needed one. You actually take more ...
(Date:7/28/2014)... 2014 Labors.at, Austria’s largest and ... Healthcare Relationship Cloud™ to fuel its growth initiatives. ... to 8,000 patients daily and performs up to ... up to doubling its volume within the next ... cutting-edge 10,000 square meter facility pushed our team ...
(Date:7/28/2014)... information about the measles, mumps and rubella (MMR) vaccine ... new University of Leeds research has found. , Informing ... helping parents make a decision about MMR is on ... informing them solely via a GP consultation, and 7.17 ... vaccine. In each case, the figure comprises the cost ...
Breaking Medicine News(10 mins):Health News:Test Results Look Promising for New Mesothelioma Blood Test, According to Surviving Mesothelioma 2Health News:Large Portions Can Decrease Food Enjoyment, SlimPlate Weight Loss System Puts Focus On Portion Control 2Health News:Large Portions Can Decrease Food Enjoyment, SlimPlate Weight Loss System Puts Focus On Portion Control 3Health News:Austrian Laboratory Leader, Labors.at, Fuels Growth with the hc1® Healthcare Relationship Cloud™ 2Health News:Online information most cost-effective means of increasing MMR uptake, research finds 2
... (AMD) is the leading cause of severe visual loss ... common genetic variants which together predict a person,s increased ... without the disease also have these variants. Now, for ... show a specific rare mutation called CFH R1210C that ...
... Chapel Hill, NC In a study published today ... of scientists including UNC biologist Jason Lieb, PhD, present ... can survive with only one copy of the X ... topic in science and provides biologists with more information ...
... EAE President Doctor Luigi Badano, FESC, from the University ... we need to acquire information from all the different ... the ESC, the EAE,s philosophy is that we want ... oriented, so that we,re using the most appropriate technology ...
... Imagine having skin so supple you could stretch it out ... - repeatedly - yet it would always snap back completely ... never need Botox. That enviable elasticity is one of ... sensor that is the latest sensor developed by Stanford,s Zhenan ...
... 23 (HealthDay News) -- Gaining a significant amount of ... risk of developing endometrial cancer, a new study suggests. ... circulating estrogen in postmenopausal women, and estrogen promotes the ... of laboratory services at the National Home Office of ...
... Fla. October 24, 2011 A new analysis of recent eye ... to reduced rates of nearsightedness, also known as myopia, in ... the United States and many other countries than it was ... percent of the population is nearsighted. The analysis suggests that ...
Cached Medicine News:Health News:Researchers ID genetic mutation associated with high risk of age-related macular degeneration 2Health News:Study confirms males and females have at least 1 thing in common: Upregulating X 2Health News:Congress alert: EUROECHO and Other Imaging Modalities: New patient emphasis 2Health News:Congress alert: EUROECHO and Other Imaging Modalities: New patient emphasis 3Health News:Stanford researchers build transparent, super-stretchy skin-like sensor 2Health News:Stanford researchers build transparent, super-stretchy skin-like sensor 3Health News:Weight Gain Might Raise Endometrial Cancer Risk 2Health News:More time outdoors may reduce kids' risk for nearsightedness 2
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of cardiac troponin I (cTnl) in human whole blood and serum specimens...
Medicine Products: